Navigation Links
The Best Enzyme for the Toughest PCR Challenges Improved with New Hot-Start Feature



Novel Herculase Hotstart DNA polymerase results in greater specificity and sensitivity

Michael Borns Brad Scott Holly Hogrefe

Stratagene

Stratagenes Herculase DNA polymerase *, is the best enzyme for difficult PCR applications, particularly those involving long, complex, low-copy number, or GC-rich templates. We have expanded our hot-start PCR enzyme product line to include Herculase Hotstart DNA polymerase.*, This polymerase provides high specificity and detection sensitivity, while facilitating high-throughput robotic PCR applications.

Stratagene is dedicated to developing high-performance PCR enzymes that excel in both routine and demanding PCR applications. We designed the novel Herculase Enhanced DNA polymerase with the goal of realizing higher product yields over an extremely broad range of target sizes and complexities.1,2 To achieve hot-start capability, Herculase Hotstart DNA polymerase is formulated with a combination of antibodies that effectively neutralize DNA polymerase and 3'-5' (proofreading) exonuclease activities. Full enzyme activity is regained once the antibody is denatured during ramp-up to initial denaturation temperatures.

Enhanced Amplification with Hot-Start Enzymes

Amplification systems that are most likely to benefit from hot start are those designed to detect low-copy-number targets in complex DNA backgrounds, are prone to primer-dimer formation, or are assembled robotically (high-throughput PCR procedu
'"/>

Source:


Page: All 1 2 3

Related biology technology :

1. Comparing Fidelity and Performance of Proofreading PCR Enzymes
2. pfuturbo DNA Polymerase: A High-Performance, High-Fidelity Enzyme Ideal for PCR Cloning
3. Greater Amplification Specificity with New Hot Start PCR Enzyme
4. Enzyme Immunoassay for Studying Intracellular Levels of cAMP
5. Improve Amplification Specificity with Hot Start PCR Enzyme
6. Choice of RT-PCR Enzymes
7. Properties of PCR Enzymes
8. Select the Optimal Enzyme for RT-PCR
9. Enzyme Purification With the Econo-Pac Q Cartridge
10. Improved Sensitivity for Staining RNA with SYBR Gold Stain
11. Improved Vectors for PathDetect Trans-Reporting Systems
Post Your Comments:
(Date:3/4/2015)... PRC Clinical, a full-service, ... Bay Area, will exhibit and present at the ... on March 25th and 26th in Tel Aviv, Israel. ... Israeli life science companies seeking to conduct U.S. Food ... span all phases of human trials, from Phase I ...
(Date:3/4/2015)... 4, 2015  BioClinica®, Inc., a leading ... today announced that clinical trial professionals representing ... its annual European User Conference in ... the use of its eClinical technologies to ... include: the Microsoft Office-Smart OnPoint CTMS; Express ...
(Date:3/4/2015)... PARIS , March 4, 2015 ... de Paris in December 2011, ... study of yttrium-90 resin microspheres versus sorafenib in advanced ... results expected late 2016.   SARAH, a ... liver cancer (hepatocellular carcinoma, or HCC) has completed patient ...
(Date:3/3/2015)... 2015 /PRNewswire/ - Aptose Biosciences Inc. (NASDAQ: APTO, TSX: ... diagnostics that target the underlying mechanisms of cancer, today ... ended December 31, 2014. Effective July 17, ... May 31 to December 31. As a result of ... for the quarter and the seven months ended December ...
Breaking Biology Technology:PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 2PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 3PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 4BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 2BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 3Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 2Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 3Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 4Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 5Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 2Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 3Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 4Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 5Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 6Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 7Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 8Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 9Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 10Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 11Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 12
... Nov. 2, 2011 Cadence Pharmaceuticals, Inc. (NASDAQ: ... developing and commercializing proprietary products principally for use in ... and CEO Ted Schroeder will present the company,s corporate ... Time (3:30pm Eastern Time) during the Credit Suisse Healthcare ...
... 2011 Quanterix Corporation, a company enabling a ... its revolutionary Si ngle Mo lecule ... analytical performance of its Prostate Specific Antigen (PSA) ... improvement in sensitivity over today,s ultrasensitive third-generation PSA ...
... In preparation for its European launch ... 50 years, Human Genome Sciences (HGS) needed a customer ... European commercial sales team. The company had a long ... mobility, industry-specific functionality, speed, and low system maintenance. Veeva ...
Cached Biology Technology:Quanterix Fifth-Generation PSA Test Enables More Sensitive Measurements Following Surgery 2Human Genome Sciences Europe Moves to the Cloud With Veeva CRM to Support New Lupus Treatment 2Human Genome Sciences Europe Moves to the Cloud With Veeva CRM to Support New Lupus Treatment 3
(Date:2/12/2015)... Feb. 12, 2015   MedNet Solutions , ... clinical study management systems, has recently bolstered its ... distinguishing iMedNet as the ... (CROs) and healthcare consultants.  Building on the Program,s ... referrals and numerous co-marketing opportunities), MedNet,s new and ...
(Date:2/9/2015)... Feb. 9, 2015  Lintec of America recently announced ... carbon nanotube (CNT) macrostructures, including sheets, yarns and ribbons, ... Leveraging the vast industrial resources of the ... , Lintec of America is forming the Nano-Science ... , focusing on scaling up the manufacturing and ...
(Date:2/5/2015)... OXFORD, Conn. , Jan. 26, 2015 NXT-ID, ... or the "Company"), a biometric authentication company focused on ... a new corporate website ( http://www.nxt-id.com/ ) as part ... Wocket™ smart wallet. The Company launched its new consumer ... Gino Pereira , CEO of NXT-ID said, "Our ...
Breaking Biology News(10 mins):MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3
... degrees Celsius. But not salt water: Due to ... is below zero. And sea water tends to freeze ... so-called "brine channels," are formed in the ice. The ... remain in a liquid state even at lower temperatures, and ...
... satellite data, a team of scientists led by researchers from ... created a model that can successfully predict the severity and ... the rest of South America months in advance. ... the primary factor that drives the distribution of fires in ...
... rely on animals for pollination, the number of seeds they ... and the successful deposition of pollen. The number of visits ... well as on conspecific plant density. But what if a ... or has very few pollinators visiting its flowers? Will all ...
Cached Biology News:CO2 bonds in sea ice: Small living creatures with major impact 2Ocean temperatures can predict Amazon fire season severity 2Ocean temperatures can predict Amazon fire season severity 3How does a plant survive with few mates or pollinators? A European herb has figured out its own way 2How does a plant survive with few mates or pollinators? A European herb has figured out its own way 3